Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

Prospective, Multicentre, Open Label, Non-controlled, 24-week Observation in Type 2 Diabetics Using Once Daily Levemir® (Insulin Detemir) as Part of Their ITT Regimen

This study is conducted in Europe. The aim of this observational study is to gain practical experience with once daily Levemir® administration in type 2 diabetes patients who were previously treated with NPH insulins (e.g. Protaphane®) as basal insulin as part of their IIT under normal clinical practice conditions in Lithuania

Inclusion Criteria:

• Type 2 diabetic subjects on intensive insulin treatment (IIT)
• Eligibility for once daily insulin detemir administration
• Informed consent obtained before any observation-related activities

Exclusion Criteria:

• Known or suspected allergy to insulin detemir
• Subjects previously enrolled in the observation
• Women who are pregnant, breast feeding or have the intention of becoming pregnant within 6 months